How many insider declarations has Jayasuriya Anula filed?

Jayasuriya Anula has filed 3 public insider declarations with SEC (Form 4).

What is Jayasuriya Anula's role?

Jayasuriya Anula's reported role is not specified by the regulator across the filings.

Which companies does Jayasuriya Anula report trades for?

Jayasuriya Anula reports trades for 2 companies, including Jaguar Health, Inc..

What is Jayasuriya Anula's declared buy vs sell volume?

Across the available history, declared buys total 10k€ and disposals 0.

← Executives ★ Sign in to follow

JA

Jayasuriya Anula

·SEC (Form 4)

Jaguar Health, Inc.Lineage Cell Therapeutics, Inc.

0

Total declarations

0

Companies

€9,848

▲ Purchases (1 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

1

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Discover the full record of transactions filed by Jayasuriya Anula. Officer active across 2 companies, notably Jaguar Health, Inc.. Aggregated, 3 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €10k. History available since 1 July 2023. The latest transaction was disclosed on 11 December 2025 (Attribution). Regulator: SEC (Form 4). All data is free.

Companies and markets linked to Jayasuriya Anula

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Jaguar Health, Inc. (US)Lineage Cell Therapeutics, Inc. (US)

Declarations3 total

◆

Jayasuriya Anula

DirectorExecutives11 Dec 2025Jaguar Health, Inc.

0SEC ↗

5,870 shares0Common StockSEC:0001193125-25-319508:0

▲

Jayasuriya Anula

DirectorExecutives29 Dec 2023Lineage Cell Therapeutics, Inc.

$10,90023SEC ↗

10,000 shares@ US$1.09100.0% of flowCommon Shares, no par valueSEC:0001493152-24-000154:0

Canonical exit: 28 Mar 2024 (T+90)

◆

Jayasuriya Anula

DirectorExecutives1 Jul 2023Jaguar Health, Inc.

0SEC ↗

1,718 shares0Common StockSEC:0001104659-23-091463:0

3 of 3 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

JA

Jayasuriya Anula

·SEC (Form 4)

Jaguar Health, Inc.Lineage Cell Therapeutics, Inc.

0

Total declarations

0

Companies

€9,848

▲ Purchases (1 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

1

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Discover the full record of transactions filed by Jayasuriya Anula. Officer active across 2 companies, notably Jaguar Health, Inc.. Aggregated, 3 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €10k. History available since 1 July 2023. The latest transaction was disclosed on 11 December 2025 (Attribution). Regulator: SEC (Form 4). All data is free.